One of the first GWAS studies evaluating treatment response variation (baseline and at weeks 4 and 12) in 65 psoriasis patients after anti-TNFα therapy found strong association of single nucleotide polymorphisms (SNPs) in JAG2 and ADRA2A, which were associated with treatment responses to anti-TNF-α agents [88]. This evidence concerns the gene TNF and psoriasis.